Operating Income (Loss) in USD of Profound Medical Corp. from 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Profound Medical Corp. quarterly/annual Operating Income (Loss) history and growth rate from 2023 to Q3 2025.
  • Profound Medical Corp. Operating Income (Loss) for the quarter ending September 30, 2025 was -$8.91M, a 0.95% increase year-over-year.
  • Profound Medical Corp. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$42.2M.
  • Profound Medical Corp. annual Operating Income (Loss) for 2024 was -$33.1M, a 15.4% decline from 2023.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Profound Medical Corp. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$42.2M -$8.91M +$85K +0.95% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 -$42.3M -$13.8M -$5.96M -76.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 -$36.4M -$11.2M -$3.29M -41.8% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$33.1M -$8.35M Oct 1, 2024 Dec 31, 2024 10-K 2025-03-07
Q3 2024 -$9M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 -$7.84M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 -$7.88M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08

Profound Medical Corp. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$33.1M -$4.41M -15.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 -$28.7M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.